243 related articles for article (PubMed ID: 10669038)
1. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats.
Kawanami T; Suzuki S; Yoshida Y; Kanai S; Takata Y; Shimazoe T; Watanabe S; Funakoshi A; Miyasaka K
Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of a synthetic trypsin inhibitor increases pancreatic duct function in CCK-A receptor-deficient rats.
Kawanami T; Funakoshi A; Suzuki S; Kanai S; Sato Y; Miyasaka K
Pancreas; 2000 May; 20(4):394-400. PubMed ID: 10824695
[TBL] [Abstract][Full Text] [Related]
3. Role of CCK-A receptor in the regulation of pancreatic bicarbonate secretion in conscious rats: a study in naturally occurring CCK-A receptor gene knockout rats.
Miyasaka K; Suzuki S; Kanai S; Masuda M; Funakoshi A
Pancreas; 1999 Oct; 19(3):217-23. PubMed ID: 10505751
[TBL] [Abstract][Full Text] [Related]
4. CCK-, secretin-, and cholinergic-independent pancreatic fluid hypersecretion in protease inhibitor-treated rats.
Yamamoto M; Shirohara H; Otsuki M
Am J Physiol; 1998 Feb; 274(2):G406-12. PubMed ID: 9486196
[TBL] [Abstract][Full Text] [Related]
5. Chronic oral administration of protease inhibitor decreases CCK-A receptor mRNA expression but increases pancreatic growth in rats.
Fukumitsu K; Nakamura H; Otsuki M
Pancreas; 2001 Mar; 22(2):179-85. PubMed ID: 11249073
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
[TBL] [Abstract][Full Text] [Related]
7. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
[TBL] [Abstract][Full Text] [Related]
8. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
Watanabe S; Takeuchi T; Chey WY
Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
[TBL] [Abstract][Full Text] [Related]
9. Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice.
Sato N; Suzuki S; Kanai S; Ohta M; Jimi A; Noda T; Takiguchi S; Funakoshi A; Miyasaka K
Jpn J Pharmacol; 2002 Jul; 89(3):290-5. PubMed ID: 12184735
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cholecystokinin release and transcription in a rat without gene expression of cholecystokinin-A receptor.
Miyasaka K; Masuda M; Funakoshi A
Digestion; 1997; 58(2):104-10. PubMed ID: 9144298
[TBL] [Abstract][Full Text] [Related]
11. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
Moriyoshi Y
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
[TBL] [Abstract][Full Text] [Related]
12. Effect of synthetic trypsin inhibitor on plasma immunoreactive cholecystokinin in rats.
Kanayama S; Himeno S; Yamasaki Y; Shinomura Y; Kitani T; Tarui S
Gastroenterol Jpn; 1987 Apr; 22(2):211-7. PubMed ID: 3596156
[TBL] [Abstract][Full Text] [Related]
13. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
Miyasaka K; Nakamura R; Kitani K
J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
[TBL] [Abstract][Full Text] [Related]
14. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J
Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
[TBL] [Abstract][Full Text] [Related]
16. Effect of a cholecystokinin (CCK) antagonist (CR 1505) on gene expressions of CCK and secretin in rat intestine.
Funakoshi A; Miyasaka K; Kawanami T; Matsumoto M; Takata Y; Kono A
Pancreas; 1995 Mar; 10(2):118-22. PubMed ID: 7716134
[TBL] [Abstract][Full Text] [Related]
17. The effect of feeding soybean trypsin inhibitor and repeated injections of cholecystokinin on rat pancreas.
Temler RS; Dormond CA; Simon E; Morel B
J Nutr; 1984 Jun; 114(6):1083-91. PubMed ID: 6202862
[TBL] [Abstract][Full Text] [Related]
18. Changes in gene expression of pancreatitis-associated protein and pancreatic secretory trypsin inhibitors in experimental pancreatitis produced by pancreatic duct occlusion in rats: comparison with gene expression of cholecystokinin and secretin.
Funakoshi A; Miyasaka K; Jimi A; Nakamura E; Teraoka H
Pancreas; 1995 Aug; 11(2):147-53. PubMed ID: 7479671
[TBL] [Abstract][Full Text] [Related]
19. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
Jyotheeswaran S; Li P; Chang TM; Chey WY
Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
[TBL] [Abstract][Full Text] [Related]
20. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
Varga G; Kisfalvi K; D'Amato M; Scarpignato C
J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
